BibTex RIS Cite

Year 2005, Volume: 3 Issue: 3, 122 - 130, 01.12.2005

Oğuzhan Durmaz Safiye Helvacı

Abstract

References

  • 1. Gershon AA, LaRussa P, Steinberg SP. Varicella zoster virus. In: Muray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken HR (eds). Manual of Clinical Microbiology (6th ed). Washington, DC: ASM Pres, 1995: 895- 904.
  • 2. Arvin AM. Varicella zoster virus: molecular virology and virus-host interactions. Curr Opin Microbiol 2001; 4:442-9.
  • 3. Gershon AA. Varicella zoster virus. In: Feigin RD, Cherry JD (eds). Texbook of pediatric Infectious Diseases (4th ed). Philadelphia: WB Saunders, 1998: 1769-77. 4. Balfour HH Jr. Inravenous acyclovir therapy for varicella in immunosuppressed children. J Pediatr 1984; 104:134-6.
  • 5. Nyerges G, Meszner Z, Gyarmayi E, Kerpel-Fronius S. Acyclovir prevents dissemination of varicella in immunocompromised children. J Infect Dis 1988; 157:309-13.
  • 6. Balfour HH, Khelly JM, Saurez CS, et al. Acyclovir treatment of varicella in otherwise healty children. J Pediatr 1990; 116:633-9.
  • 7. Dunkle ML, Arvin AM, Whitley RJ, et al. A controlled trial of acyclovir for chickenpox in normal children. N Engl J Med 1991; 325:1539-44.
  • 8. Weitekamp MR, Schan P, Aber RC. An algoritmh for the control of nosocomial varicella-zoster virus infection. Am J Infect Control 1985; 13:193-8.
  • 9. American Academy of Pediatrics. Varicella-zoster infections. In: Pickering LK (eds). 2000 Red Book: Report of the Committee on Infectious Diseases (25th ed). Elk Groove Village, IL American Academy of Pediatrics, 2000: 624-38.
  • 10. Rawson H, Crampin A, Noah N. Deaths from chickenpox in England and Wales 1995-1997: analysis of routine mortality data. BMJ 2001; 323: 1091-3. 11. Seward JF. Update on varicella. Pediatr Infect Dis J 2001; 20: 619-621.
  • 12. Straus SE. Varicella virus immunity and prevention: a conference perspective. Arch Virol Suppl 2001; 17: 173-178.
  • 13. CDC. Preventetion of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMMR 1996; 45 (NO. RR-11).
  • 14. CDC. Preventetion of varicella: update recommendations of the Advisory Committee on Immunization Practices (ACIP). MMMR 1999; 48 (No. RR-6).
  • 15. Linder N, Ferber A, Kopilov U, et al. Reported exposure to chickenpox: a predictor of positive anti-varicella-zoster antibodies in parturient women. Fetal Diagn Ther 2001; 16:423-6.
  • 16. Ronan K, Wallace MR. The utility of serologic testing for varicella in an adolescent population. Vaccine 2001; 19:4700-2.
  • 17. Villasis-Keever MA, Pena LA, Miranda-Novales G, et al. Prevelence of serological markers againts measles, rubella, varicella, hepatitis B, hepatitis C, and human immunodeficiency virus among Medical residents in Mexico. Prev Med 2001; 32:424-8.
  • 18. Herel Z, Ipp L, Rigggs S, Vaz R, Flanagan P. Serotesting versus presumptive varicella vaccination of adolescents with a negative bor uncertain history of chickenpox. J Adolesc Health 2001; 28:26-9.
  • 19. Struawing JP, Hyams KC, Tueller JE, Gray GC. The risk of measles, mumps, and varicella among young adults: a serosurvey of US Navy and Marine Corps resruits. Am J Public Health 1993; 83:1717-20.
  • 20. Fehr T, Bossart W, Wahl C, Binswanger U. Disseminated varicella infection in adult Renal allograft recipients: four cases and a review of the literature. Transplantation 2002; 73:608-11.
  • 21. Gershon AA. Prevention and Treatment of VZV infections in patients with HIV. Herpes 2001; 8:32-26.
  • 22. Morgan R, King D. Shingles: a review of diagnosis and management. Hosp Med 1998; 59:770-6.
  • 23. Sauerbrei A, Wutzler P. Neonatal varicella. J Perinatol 2001; 21:545-9.
  • 24. Goldman DA. Transmission of infectious diseases in children. Pediatr Rev 1992; 13:283-93.
  • 25. Drwal-Klein LA, O'Donovan CA. Varicella in pediatric patients. Ann Pharmacother 1993; 27:938-49.
  • 26. Kleinschmidt- DeMaster BK, Gilden DH. Varicella virus infections of the nervous system:Clinical and pathologic correlates. Arc Pathol Lab Med 2001; 125:770-80.
  • 27. Mahalingam R, Kennedy PG,Gilden DH. The problems of latent varicella zoster virus in human ganglia: precise cell location and viral content. J Neurovirol 1999; 5:445-8.
  • 28. Weller TH. Varicella and herpes zoster: a perspective and overview. J Infect Dis 1992; 166 Suppl 1: S1-S6.
  • 29. Artvin Am. ‹mmune responses to varicella zoster virus. Infect Dis Clin North Am 1996; 10:529-70.
  • 30. Bernstein HH, Rothstein EP, Watson BM, et al. Clinical survey of natural varicella after immunization with live attenuated Oka/Merc varicella vaccine. Pediatrics 1993; 92:833-7.
  • 31. White Cj, Kuter BJ, Ngai A et al. Modified cases of chinkenpox after varicella vaccination: correlation of preotection with antibody response. Pediatr Infect D›s J 1992; 11:19-23.
  • 32. Watson BM, Piercy SA, Plotkin SA, Star SE. Modified chickenpox in children immunized with the Oka/Merck varicella vaccine. Pediatrics 1993; 91:17-22.
  • 33. Schwartz B, Facklam RR, Breiman RF. Changing epidemiology of Group A streptococcal infection in the USA. Lanset 1990; 336:1167-71.
  • 34. Vugia DJ, Peterson CL, Meyers HB, et al. Invasive group A streptococcal infections in children with varicella in southern California. Pediatr ‹nfect Dis J 1996; 15:146-50.
  • 35. Peterson CL, Mascola L, Chao sm, et al. Children hospitalized for varicella: a prevaccine review. J Pediatr 1996; 129:529-36.
  • 36. Echevarria JM, Casas I, Martinez-Martin P. Infections of the nervous system caused by varicella zoster virus: a review. ‹ntervirology 1997; 40:72-84.
  • 37. Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, Mahalingam R, Cohrs RJ. Neurologic complication of the reactivation of varicella-zoster virus. N Engl J Med 2000; 342: 635-45.
  • 38. Tseng HW, Liu CC, Wang SM, Yang YJ, Huang YS. Complications of varicella in children: emphasis on skin and central nervous system disorder. J Microbiol Immunol Infect 2000; 33:248-52.
  • 39. Larsen SU. Reye's syndrome. Med Sci Law 1997; 37:235-341.
  • 40. Valencia AM, Quevedo FW, Quintos LS. Reye's syndrome: not of historical interest only. Pediatr ‹nfect Dis J 1997; 16:1011-2.
  • 41. Chua HC, Tjia H, Sitoh YY. Concurrent myelitis and Guilliain-Barre syndrome after varicella infection. Int J Clin Pract 2001; 55:643-4.
  • 42. Roccataglia L, Ucceli A, Murialdo A. Guillain-Barre syndrome after reactivation of varicella -zoster Virus. N Eng J Med 2001; 344:65-6.
  • 43. Feldman S, Crout JD, Andrew ME. ‹ncidence and natural history of chemically defined varicella-zoster virus hepatitis in children and adolescents. Scand J Infect Dis 1997; 29:33-6.
  • 44. Borum ML, Zimmerman HJ. Hepatitis associated with varicella infection in an immunocompetent adult. J Clin Gastroenterol 1996; 23:165.
  • 45. Ziebold C, von Kries R, Lang R, Weigl J, Schimitt HJ. Severe comlications of varicella in previously healthy children in Germany: a 1-year survey. Pediatrics 2001; 108:E79.
  • 46. Rand Ml, Wright JF. Virus- associated idiopathic thrombocytopenic purpura. Transfus Sci 1998; 19:253-9.
  • 47. Roberts N, Peek GJ, Jones N, Firmin RK, Elbourne D. Deaths from chickenpox. Extracorporeal membrane oxygenation has important role. BMJ 2002; 324:610-1.
  • 48. Jones AM, Thomas N, Wilkins EG. Outcome of Varicella pneumonitis in immunocompetent adults requiring treatment in a high dependency unit. J ‹nfect 2001; 43:135-9.
  • 49. Gearte SC, Tarver RD. Diagnostic case study: varicella pneumonia. Semin Respir ‹nfect 1998; 13:353-5.
  • 50. Haris RE, Rhoades ER. Varicella pneumonia complicating pregnancy: Report of a case and review of the literature. Obstet Gynecol 1965; 25:734-40.
  • 51. McCarter-Spaulding DE. aricella infection in pregnancy. J Obstet Gynecol Neonatal Nurs 2001; 30:667-73.
  • 52. Sauerbrei A, Wutzler P. The congenital varicella syndrome. J Perinatol 2000; 20:548-54.
  • 53. Fehr T, Bossart W, Wahl C, Binswanger U. Disseminated varicella infection in adult renal allograft recipients: four cases and a review of the literature. Transplantation 2002; 73:608-11.
  • 54. Cohen Pr. Tests for detecting herpes simplex virus and varicella-zoster virus infections. Dermatol Clin 1994; 12:51-68.
  • 55. Snoeck R, Andrei G, De Clercg E. Current pharmacologial approaches to the therapy of varicella zoster virus infections: a quide to treatment. Drugs 1999; 57:187-206.
  • 56. Keating Mr. Antiviral agents for non-human immunodeficiency virus infections . Mayo Clin Proc 1999; 74:1266-83.
  • 57. Arvin AM, Management of varicella zoster virus infections in children. Adv Exp Med Biol 1999; 458:167-74.
  • 58. Balzarini J, Naesens L, Clercq ED. New antivirals mechanism of action and resistance development. Curr Opin Microbiol 1998; 1:535-46.
  • 59. Balfour HH. Antiviral drugs. N Engl J Med 1999; 340:1255-68.
  • 60. Rajan P, Rivers JK. Varicella zoster virus. Recent advences in management. Can Fam Physician 2001; 47:2299-3204.
  • 61. Weintrub PS. Uses of immune globulins in the prophylaxis and treatment of viral infections. Clin Lab Med 1987; 7:897-910.
  • 62. Kanra G, Tezcan S, Badur S; Turkish National Study Team. Varicella seroprevalence in a random sample of the Turkish population. Vaccine 2002; 20:1425-8.
  • 63. MMWR. Simultaneous administration of varicella vaccine and other recommended childhood vaccines-United States, 1995-1999. MMWR 2001; 50:1058-61.
  • 64. Ozkan S, Maral I, Ilhan F, Aycan S, Betazova U, Aygun R. Varicella Zoster Seroprevalence in Children less than 5 years old. J Trop Pediatr.2005; 51:141-4.

Çocuklarda Suçiçeği Enfeksiyonu ve Bağışıklama

Year 2005, Volume: 3 Issue: 3, 122 - 130, 01.12.2005

Oğuzhan Durmaz Safiye Helvacı

Abstract

Variella Zoster Virüsu VZV , suçiçeği Suçiçeği ya da Chickenpox ve zona Herpes zoster ya da Shingles denen hastalığın etkenidir. Suçiçeği sıklıkla çocuklarda ateş ve jeneralize veziküler döküntü ile karakterize, hafif seyirli, çok bulaşıcı bir hastalıktır. VZV primer enfeksiyondan sonra arka sinir köklerine yerleşir. Zona dorsal ganglionlara yerleşen virusun reaktivasyonu sonucu gelişen sıklıkla yaşamın ilerleyen dönemlerinde, latent kaldı- ğı ganglionun inervasyonunu aldığı dermatom bölgesinde veziküler lezyonlarla ortaya çıkar 1,2 .

References

  • 1. Gershon AA, LaRussa P, Steinberg SP. Varicella zoster virus. In: Muray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken HR (eds). Manual of Clinical Microbiology (6th ed). Washington, DC: ASM Pres, 1995: 895- 904.
  • 2. Arvin AM. Varicella zoster virus: molecular virology and virus-host interactions. Curr Opin Microbiol 2001; 4:442-9.
  • 3. Gershon AA. Varicella zoster virus. In: Feigin RD, Cherry JD (eds). Texbook of pediatric Infectious Diseases (4th ed). Philadelphia: WB Saunders, 1998: 1769-77. 4. Balfour HH Jr. Inravenous acyclovir therapy for varicella in immunosuppressed children. J Pediatr 1984; 104:134-6.
  • 5. Nyerges G, Meszner Z, Gyarmayi E, Kerpel-Fronius S. Acyclovir prevents dissemination of varicella in immunocompromised children. J Infect Dis 1988; 157:309-13.
  • 6. Balfour HH, Khelly JM, Saurez CS, et al. Acyclovir treatment of varicella in otherwise healty children. J Pediatr 1990; 116:633-9.
  • 7. Dunkle ML, Arvin AM, Whitley RJ, et al. A controlled trial of acyclovir for chickenpox in normal children. N Engl J Med 1991; 325:1539-44.
  • 8. Weitekamp MR, Schan P, Aber RC. An algoritmh for the control of nosocomial varicella-zoster virus infection. Am J Infect Control 1985; 13:193-8.
  • 9. American Academy of Pediatrics. Varicella-zoster infections. In: Pickering LK (eds). 2000 Red Book: Report of the Committee on Infectious Diseases (25th ed). Elk Groove Village, IL American Academy of Pediatrics, 2000: 624-38.
  • 10. Rawson H, Crampin A, Noah N. Deaths from chickenpox in England and Wales 1995-1997: analysis of routine mortality data. BMJ 2001; 323: 1091-3. 11. Seward JF. Update on varicella. Pediatr Infect Dis J 2001; 20: 619-621.
  • 12. Straus SE. Varicella virus immunity and prevention: a conference perspective. Arch Virol Suppl 2001; 17: 173-178.
  • 13. CDC. Preventetion of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMMR 1996; 45 (NO. RR-11).
  • 14. CDC. Preventetion of varicella: update recommendations of the Advisory Committee on Immunization Practices (ACIP). MMMR 1999; 48 (No. RR-6).
  • 15. Linder N, Ferber A, Kopilov U, et al. Reported exposure to chickenpox: a predictor of positive anti-varicella-zoster antibodies in parturient women. Fetal Diagn Ther 2001; 16:423-6.
  • 16. Ronan K, Wallace MR. The utility of serologic testing for varicella in an adolescent population. Vaccine 2001; 19:4700-2.
  • 17. Villasis-Keever MA, Pena LA, Miranda-Novales G, et al. Prevelence of serological markers againts measles, rubella, varicella, hepatitis B, hepatitis C, and human immunodeficiency virus among Medical residents in Mexico. Prev Med 2001; 32:424-8.
  • 18. Herel Z, Ipp L, Rigggs S, Vaz R, Flanagan P. Serotesting versus presumptive varicella vaccination of adolescents with a negative bor uncertain history of chickenpox. J Adolesc Health 2001; 28:26-9.
  • 19. Struawing JP, Hyams KC, Tueller JE, Gray GC. The risk of measles, mumps, and varicella among young adults: a serosurvey of US Navy and Marine Corps resruits. Am J Public Health 1993; 83:1717-20.
  • 20. Fehr T, Bossart W, Wahl C, Binswanger U. Disseminated varicella infection in adult Renal allograft recipients: four cases and a review of the literature. Transplantation 2002; 73:608-11.
  • 21. Gershon AA. Prevention and Treatment of VZV infections in patients with HIV. Herpes 2001; 8:32-26.
  • 22. Morgan R, King D. Shingles: a review of diagnosis and management. Hosp Med 1998; 59:770-6.
  • 23. Sauerbrei A, Wutzler P. Neonatal varicella. J Perinatol 2001; 21:545-9.
  • 24. Goldman DA. Transmission of infectious diseases in children. Pediatr Rev 1992; 13:283-93.
  • 25. Drwal-Klein LA, O'Donovan CA. Varicella in pediatric patients. Ann Pharmacother 1993; 27:938-49.
  • 26. Kleinschmidt- DeMaster BK, Gilden DH. Varicella virus infections of the nervous system:Clinical and pathologic correlates. Arc Pathol Lab Med 2001; 125:770-80.
  • 27. Mahalingam R, Kennedy PG,Gilden DH. The problems of latent varicella zoster virus in human ganglia: precise cell location and viral content. J Neurovirol 1999; 5:445-8.
  • 28. Weller TH. Varicella and herpes zoster: a perspective and overview. J Infect Dis 1992; 166 Suppl 1: S1-S6.
  • 29. Artvin Am. ‹mmune responses to varicella zoster virus. Infect Dis Clin North Am 1996; 10:529-70.
  • 30. Bernstein HH, Rothstein EP, Watson BM, et al. Clinical survey of natural varicella after immunization with live attenuated Oka/Merc varicella vaccine. Pediatrics 1993; 92:833-7.
  • 31. White Cj, Kuter BJ, Ngai A et al. Modified cases of chinkenpox after varicella vaccination: correlation of preotection with antibody response. Pediatr Infect D›s J 1992; 11:19-23.
  • 32. Watson BM, Piercy SA, Plotkin SA, Star SE. Modified chickenpox in children immunized with the Oka/Merck varicella vaccine. Pediatrics 1993; 91:17-22.
  • 33. Schwartz B, Facklam RR, Breiman RF. Changing epidemiology of Group A streptococcal infection in the USA. Lanset 1990; 336:1167-71.
  • 34. Vugia DJ, Peterson CL, Meyers HB, et al. Invasive group A streptococcal infections in children with varicella in southern California. Pediatr ‹nfect Dis J 1996; 15:146-50.
  • 35. Peterson CL, Mascola L, Chao sm, et al. Children hospitalized for varicella: a prevaccine review. J Pediatr 1996; 129:529-36.
  • 36. Echevarria JM, Casas I, Martinez-Martin P. Infections of the nervous system caused by varicella zoster virus: a review. ‹ntervirology 1997; 40:72-84.
  • 37. Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, Mahalingam R, Cohrs RJ. Neurologic complication of the reactivation of varicella-zoster virus. N Engl J Med 2000; 342: 635-45.
  • 38. Tseng HW, Liu CC, Wang SM, Yang YJ, Huang YS. Complications of varicella in children: emphasis on skin and central nervous system disorder. J Microbiol Immunol Infect 2000; 33:248-52.
  • 39. Larsen SU. Reye's syndrome. Med Sci Law 1997; 37:235-341.
  • 40. Valencia AM, Quevedo FW, Quintos LS. Reye's syndrome: not of historical interest only. Pediatr ‹nfect Dis J 1997; 16:1011-2.
  • 41. Chua HC, Tjia H, Sitoh YY. Concurrent myelitis and Guilliain-Barre syndrome after varicella infection. Int J Clin Pract 2001; 55:643-4.
  • 42. Roccataglia L, Ucceli A, Murialdo A. Guillain-Barre syndrome after reactivation of varicella -zoster Virus. N Eng J Med 2001; 344:65-6.
  • 43. Feldman S, Crout JD, Andrew ME. ‹ncidence and natural history of chemically defined varicella-zoster virus hepatitis in children and adolescents. Scand J Infect Dis 1997; 29:33-6.
  • 44. Borum ML, Zimmerman HJ. Hepatitis associated with varicella infection in an immunocompetent adult. J Clin Gastroenterol 1996; 23:165.
  • 45. Ziebold C, von Kries R, Lang R, Weigl J, Schimitt HJ. Severe comlications of varicella in previously healthy children in Germany: a 1-year survey. Pediatrics 2001; 108:E79.
  • 46. Rand Ml, Wright JF. Virus- associated idiopathic thrombocytopenic purpura. Transfus Sci 1998; 19:253-9.
  • 47. Roberts N, Peek GJ, Jones N, Firmin RK, Elbourne D. Deaths from chickenpox. Extracorporeal membrane oxygenation has important role. BMJ 2002; 324:610-1.
  • 48. Jones AM, Thomas N, Wilkins EG. Outcome of Varicella pneumonitis in immunocompetent adults requiring treatment in a high dependency unit. J ‹nfect 2001; 43:135-9.
  • 49. Gearte SC, Tarver RD. Diagnostic case study: varicella pneumonia. Semin Respir ‹nfect 1998; 13:353-5.
  • 50. Haris RE, Rhoades ER. Varicella pneumonia complicating pregnancy: Report of a case and review of the literature. Obstet Gynecol 1965; 25:734-40.
  • 51. McCarter-Spaulding DE. aricella infection in pregnancy. J Obstet Gynecol Neonatal Nurs 2001; 30:667-73.
  • 52. Sauerbrei A, Wutzler P. The congenital varicella syndrome. J Perinatol 2000; 20:548-54.
  • 53. Fehr T, Bossart W, Wahl C, Binswanger U. Disseminated varicella infection in adult renal allograft recipients: four cases and a review of the literature. Transplantation 2002; 73:608-11.
  • 54. Cohen Pr. Tests for detecting herpes simplex virus and varicella-zoster virus infections. Dermatol Clin 1994; 12:51-68.
  • 55. Snoeck R, Andrei G, De Clercg E. Current pharmacologial approaches to the therapy of varicella zoster virus infections: a quide to treatment. Drugs 1999; 57:187-206.
  • 56. Keating Mr. Antiviral agents for non-human immunodeficiency virus infections . Mayo Clin Proc 1999; 74:1266-83.
  • 57. Arvin AM, Management of varicella zoster virus infections in children. Adv Exp Med Biol 1999; 458:167-74.
  • 58. Balzarini J, Naesens L, Clercq ED. New antivirals mechanism of action and resistance development. Curr Opin Microbiol 1998; 1:535-46.
  • 59. Balfour HH. Antiviral drugs. N Engl J Med 1999; 340:1255-68.
  • 60. Rajan P, Rivers JK. Varicella zoster virus. Recent advences in management. Can Fam Physician 2001; 47:2299-3204.
  • 61. Weintrub PS. Uses of immune globulins in the prophylaxis and treatment of viral infections. Clin Lab Med 1987; 7:897-910.
  • 62. Kanra G, Tezcan S, Badur S; Turkish National Study Team. Varicella seroprevalence in a random sample of the Turkish population. Vaccine 2002; 20:1425-8.
  • 63. MMWR. Simultaneous administration of varicella vaccine and other recommended childhood vaccines-United States, 1995-1999. MMWR 2001; 50:1058-61.
  • 64. Ozkan S, Maral I, Ilhan F, Aycan S, Betazova U, Aygun R. Varicella Zoster Seroprevalence in Children less than 5 years old. J Trop Pediatr.2005; 51:141-4.
There are 62 citations in total.

Details

Primary Language Turkish
Journal Section Collection
Authors

Oğuzhan Durmaz This is me

Safiye Helvacı This is me

Publication Date December 1, 2005
Published in Issue Year 2005 Volume: 3 Issue: 3

Cite

APA Durmaz, O., & Helvacı, S. (2005). Çocuklarda Suçiçeği Enfeksiyonu ve Bağışıklama. Güncel Pediatri, 3(3), 122-130.
AMA Durmaz O, Helvacı S. Çocuklarda Suçiçeği Enfeksiyonu ve Bağışıklama. Güncel Pediatri. December 2005;3(3):122-130.
Chicago Durmaz, Oğuzhan, and Safiye Helvacı. “Çocuklarda Suçiçeği Enfeksiyonu Ve Bağışıklama”. Güncel Pediatri 3, no. 3 (December 2005): 122-30.
EndNote Durmaz O, Helvacı S (December 1, 2005) Çocuklarda Suçiçeği Enfeksiyonu ve Bağışıklama. Güncel Pediatri 3 3 122–130.
IEEE O. Durmaz and S. Helvacı, “Çocuklarda Suçiçeği Enfeksiyonu ve Bağışıklama”, Güncel Pediatri, vol. 3, no. 3, pp. 122–130, 2005.
ISNAD Durmaz, Oğuzhan - Helvacı, Safiye. “Çocuklarda Suçiçeği Enfeksiyonu Ve Bağışıklama”. Güncel Pediatri 3/3 (December 2005), 122-130.
JAMA Durmaz O, Helvacı S. Çocuklarda Suçiçeği Enfeksiyonu ve Bağışıklama. Güncel Pediatri. 2005;3:122–130.
MLA Durmaz, Oğuzhan and Safiye Helvacı. “Çocuklarda Suçiçeği Enfeksiyonu Ve Bağışıklama”. Güncel Pediatri, vol. 3, no. 3, 2005, pp. 122-30.
Vancouver Durmaz O, Helvacı S. Çocuklarda Suçiçeği Enfeksiyonu ve Bağışıklama. Güncel Pediatri. 2005;3(3):122-30.